Stock VIV AVIVAGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Avivagen Inc. Share Price

Equities

VIV

CA05382F2026

Fishing & Farming

Delayed Toronto S.E.
Other stock markets
 08:00:00 05/03/2024 pm IST 		5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for Avivagen Inc. -.--% -.--%
2023 Avivagen Inc. Announces New 500 Kg Order for OxC-beta CI
2023 Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 CI

Financials

Sales 2021 1.3M 947K 79.03M Sales 2022 939K 687K 57.27M Capitalization 10.42M 7.62M 635M
Net income 2021 -6M -4.39M -366M Net income 2022 -6M -4.39M -366M EV / Sales 2021 21.5 x
Net Debt 2021 5.4M 3.95M 329M Net Debt 2022 5.8M 4.24M 353M EV / Sales 2022 17.3 x
P/E ratio 2021
-3.24 x
P/E ratio 2022
-1.47 x
Employees 13
Yield 2021 *
-
Yield 2022
-
Free-Float 98.89%
More Fundamentals * Assessed data

Chart Avivagen Inc.

Dynamic Chart

Latest news about Avivagen Inc.

Avivagen Inc. Announces New 500 Kg Order for OxC-beta CI
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 CI
Avivagen Brief: Announcing several corporate updates, relating to allowances of patents, a waiver of an interest payment on its senior secured debentures and continuation of the strategic review process MT
Avivagen Secures New Orders for 1.1 Tons of Oxc-Beta Livestock Product MT
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta? Livestock Product CI
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023 CI
Avivagen Reports Increase in Sales to Existing Customer MT
Avivagen Inc. Announces Significant Increase in Sales to an Existing Customer CI
Avivagen Brief: Announcing "Significant" Increase in Sales to an Existing Customer MT
Avivagen Launches Strategic Review; Comes After Soaring 50% Yesterday MT
Avivagen Brief: Announcing Review of Strategic Alternatives MT
Avivagen Announces Review of Strategic Alternatives CI
Avivagen Inc. Announces Board Changes CI
Avivagen Narrows Fiscal Q1 Loss, Revenue Falls; Says Will Need Cash Proceeds to Continue as Going Concern MT
Avivagen Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023 CI
More news

Press releases Avivagen Inc.

Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA NE
Canadian Investment Regulatory Organization Trading Halt - VIV AQ
Avivagen Announces Significant Increase in Sales to an Existing Customer AQ
Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth AQ
Avivagen Announces Foundational Scientific and Commercial Evidence of OxC-Beta Product Published in Peer-Reviewed Journal AQ
More press releases

News in other languages on Avivagen Inc.

Avivagen anuncia su nuevo cliente de productos lácteos en México
Avivagen : anuncia la inminente publicación de una investigación que destaca los beneficios de OxC-betaTM Livestock para las aves de corral de engorde
Avivagen : confía en Meyenberg International Group para dirigir sus actividades de expansión en América Central y del Sur
Avivagen : anuncia la publicación de su OxC-beta en Nueva Zelanda™ Ensayo realizado en ganado lechero para uso contra la mastitis subclínica
Avivagen : anuncia un pedido de seis toneladas de OxC-beta™ Livestock de un nuevo cliente en México
More news

Highs and lows

Current year
0.01
Extreme 0.005
0.01
1 year
0.01
Extreme 0.005
0.03
3 years
0.01
Extreme 0.005
0.58
5 years
0.00
Extreme 0
0.84
10 years
0.00
Extreme 0
2.15
More quotes

Managers and Directors - Avivagen Inc.

Managers TitleAgeSince
Graham W. Burton FOU
 Founder - 04/05/04
G. Anthony CEO
 Chief Executive Officer 68 04/14/04
Ira Levy DFI
 Director of Finance/CFO - -
Members of the board TitleAgeSince
Jeffrey Kraws CHM
 Chairman 59 01/13/01
Aubrey Dan BRD
 Director/Board Member - 22/17/22
G. Anthony CEO
 Chief Executive Officer 68 04/14/04
More insiders

Company Profile

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.
Sector
Fishing & Farming
Calendar
04/06/2024 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Animal Feed

1st Jan change Capi.
AVIVAGEN INC. Stock Avivagen Inc.
-.--% 284K
GUANGDONG HAID GROUP CO., LIMITED Stock Guangdong Haid Group Co., Limited
+11.33% 11.43B
NEW HOPE LIUHE CO.,LTD. Stock New Hope Liuhe Co.,Ltd.
-0.75% 5.77B
PT CHAROEN POKPHAND INDONESIA TBK Stock PT Charoen Pokphand Indonesia Tbk
-4.08% 4.87B
CHAROEN POKPHAND FOODS Stock Charoen Pokphand Foods
-5.10% 4.14B
BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD. Stock Beijing Dabeinong Technology Group Co.,Ltd.
-23.66% 2.58B
AKTIESELSKABET SCHOUW & CO. Stock Aktieselskabet Schouw & Co.
-5.06% 1.75B
TANGRENSHEN GROUP CO., LTD Stock Tangrenshen Group Co., Ltd
-24.53% 1.11B
WELLHOPE FOODS CO., LTD. Stock Wellhope Foods Co., Ltd.
-18.46% 865M
AVANTI FEEDS LIMITED Stock Avanti Feeds Limited
+24.67% 855M
Animal Feed
  1. Stock Market
  2. Equities
  3. VIV Stock